Gates Package — page 200
of 1375 pages
← p.199 p.201 → · this page in the original PDF · package
G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023
Reference# I Agreement Type
Effective Date Expiration Dz External Parties
*Lead Pl
2014-24759
CRADA
6/12/2015]
6/12/2025] Pharming Technologies B.V.
Michael Lenardo
2014-24759
|CRADA
6/12/2015]
6/12/2025|Novartis Pharmaceuticals Corporation [US]
Michael Lenardo
2014-24778 =
|Gift
11/2/2014}
European Commission [EU]
Stephen Leppla
GLAXO WELLCOME, INC. (now GlaxoSmithKline;
2014-24849
_|Letter of Intent/MOU
12/3/2014
GSK)
GLAXO WELLCOME, INC. (now GlaxoSmithKline;
2014-24849
_|Letter of Intent/MOU
12/3/2014
GSK)
2014-24864
|Gift
1/5/2015}
1/1/2018} Cancer Research Institute [US]
Yasmine Belkaid
2014-24864
{Gift
1/5/2015)
1/1/2018] Cancer Research Institute [US]
Yasmine Belkaid
2014-24889 _ |Research Collaboration Agreement
10/29/2014]
10/28/2017 I Pisces Therapeutics, LLC
Dean Metcalfe
2014-24902
Research Collaboration Agreement
10/23/2015]
10/23/2017 I Codagenix Inc.
Jeffrey Cohen
2014-24914 _| Research Collaboration Agreement
9/19/2015]
9/19/2017]La Jolla Institute for Allergy & Immunology
Pamela Guerrerio
2014-24929
Research Collaboration Agreement
6/27/2015]
6/27/2018] University of California-San Francisco (UCSF)
Steven Holland
2014-24940 __| Research Collaboration Agreement
1/11/2016]
1/11/2019]|Johns Hopkins Medicine (JHM)
Pamela Guerrerio
2014-24971
Research Collaboration Agreement
2/4/2016}
WCCT Global
Mathew Memoli
2014-24971
|Research Collaboration Agreement
2/4/2016
WCCT Global
Mathew Memoli
Massachusetts General Hospital (MGH; General
2014-25076 I CTA- Clinical Trial Agreement
6/4/2015)
Hospital Corp.)
Colleen Hadigan
Naval Medical Research Center (NMRC) (DoD),
2014-25098 _ |Research Collaboration Agreement
5/6/2016
5/6/2019} Sanaria, Inc. (see also Protein Potential)
Patrick Duffy
United States Army Medical Research Institute of
2014-25111
Letter of Intent/MOU
12/16/2014]
Infectious Diseases (USAMRIID)
Heinrich Feldmann
2014-25138
|Research Collaboration Agreement
4/13/2015}
4/13/2020|GeoVax, Inc.
2014-25138
Research Collaboration Agreement
4/13/2015]
4/13/2020}GeoVax, Inc.
2014-25148
|Research Collaboration Agreement
1/29/2015}
Google [US]
Martin Meier-Sche
2014-25148 _ |Research Collaboration Agreement
1/29/2015}
Google [US]
Martin Meier-Sche
BioAegis Therapeutics, Inc., NIH Clinical Center
2014-25153
Research Collaboration Agreement
12/21/2014]
12/21/2017 I(CC/NIH)
Kol ZAREMBER
2014-25157
Letter of Intent/MOU
4/7/2015}
Bill & Melinda Gates Foundation (BMGF)
David Sacks
American Academy of Allergy Asthma and
2014-25168
_|Gift
3/23/2015
7/1/2016] Immunology
Jonathan Lyons
GlaxoSmithKline Biologicals SA (GSK Biologicals,
2014-25218 I CTA- Clinical Trial Agreement
1/21/2015}
GSK) [BE]
H Clifford Lane
2014-25228
|Research Collaboration Agreement
5/4/2015)
Biocartis
Peter Jahrling
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/200
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00093 | — | attachment | 200 |